APO Research

APO RESEARCH · REPORT

Veterinary Pain Medication

Selected research

Market Analysis & Forecast

Global Veterinary Pain Medication Market Analysis and Forecast 2026-2032

Market perspective

The global Veterinary Pain Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Veterinary Pain Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Pain Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Pain Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Pain Medication is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Veterinary Pain Medication include Zoetis, Ringpu Bio-technology, Ruicheng Lvman Biological Pharmaceutical Co., Ltd., Merck & Co, Medtronic, Lilly, Pfizer, Harbin Bolai Pharmaceutical Co., Ltd. and Bostonscientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Veterinary Pain Medication, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Pain Medication, also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Pain Medication, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Pain Medication sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Pain Medication market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Pain Medication sales, projected growth trends, production technology, application and end-user industry.

Veterinary Pain Medication Segment by Company

Zoetis

Ringpu Bio-technology

Ruicheng Lvman Biological Pharmaceutical Co., Ltd.

Merck & Co

Medtronic

Lilly

Pfizer

Harbin Bolai Pharmaceutical Co., Ltd.

Bostonscientific

Bayer Pharma AG

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Boehringer Ingelheim

Veterinary Pain Medication Segment by Type

Injection Medicines

Oral Medicines

Veterinary Pain Medication Segment by Application

Veterinary Hospitals

Veterinary Clinics

Others

Veterinary Pain Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Pain Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Pain Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Pain Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Pain Medication in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Pain Medication manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Pain Medication sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Pain Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Medicines Major Manufacturers Table 3. Oral Medicines Major Manufacturers Table 4. Global Veterinary Pain Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Veterinary Hospitals Major Manufacturers Table 6. Veterinary Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Veterinary Pain Medication Industry Trends Table 9. Veterinary Pain Medication Industry Drivers Table 10. Veterinary Pain Medication Industry Opportunities and Challenges Table 11. Veterinary Pain Medication Industry Restraints Table 12. Global Veterinary Pain Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Veterinary Pain Medication Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Veterinary Pain Medication Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Veterinary Pain Medication Revenue Market Share by Region (2021-2026) Table 16. Global Veterinary Pain Medication Revenue Market Share by Region (2027-2032) Table 17. Global Veterinary Pain Medication Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Veterinary Pain Medication Sales by Region (2021-2026) & (k units) Table 19. Global Veterinary Pain Medication Sales by Region (2027-2032) & (k units) Table 20. Global Veterinary Pain Medication Sales Market Share by Region (2021-2026) Table 21. Global Veterinary Pain Medication Sales Market Share by Region (2027-2032) Table 22. Global Veterinary Pain Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Veterinary Pain Medication Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Veterinary Pain Medication Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Veterinary Pain Medication Sales Market Share by Manufacturers (2021-2026) Table 26. Global Veterinary Pain Medication Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Veterinary Pain Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Veterinary Pain Medication Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Veterinary Pain Medication Manufacturers, Product Type & Application Table 30. Global Veterinary Pain Medication Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Veterinary Pain Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Veterinary Pain Medication Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Veterinary Pain Medication Revenue Market Share by Type (2021-2026) Table 37. Global Veterinary Pain Medication Revenue Market Share by Type (2027-2032) Table 38. Global Veterinary Pain Medication Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 40. Global Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 41. Global Veterinary Pain Medication Sales Market Share by Type (2021-2026) Table 42. Global Veterinary Pain Medication Sales Market Share by Type (2027-2032) Table 43. Global Veterinary Pain Medication Price by Type (2021-2026) & (US$/unit) Table 44. Global Veterinary Pain Medication Price by Type (2027-2032) & (US$/unit) Table 45. Global Veterinary Pain Medication Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Veterinary Pain Medication Revenue Market Share by Application (2021-2026) Table 49. Global Veterinary Pain Medication Revenue Market Share by Application (2027-2032) Table 50. Global Veterinary Pain Medication Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 52. Global Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 53. Global Veterinary Pain Medication Sales Market Share by Application (2021-2026) Table 54. Global Veterinary Pain Medication Sales Market Share by Application (2027-2032) Table 55. Global Veterinary Pain Medication Price by Application (2021-2026) & (US$/unit) Table 56. Global Veterinary Pain Medication Price by Application (2027-2032) & (US$/unit) Table 57. Zoetis Company Information Table 58. Zoetis Business Overview Table 59. Zoetis Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Zoetis Veterinary Pain Medication Product Portfolio Table 61. Zoetis Recent Development Table 62. Ringpu Bio-technology Company Information Table 63. Ringpu Bio-technology Business Overview Table 64. Ringpu Bio-technology Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Ringpu Bio-technology Veterinary Pain Medication Product Portfolio Table 66. Ringpu Bio-technology Recent Development Table 67. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information Table 68. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview Table 69. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 71. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Development Table 72. Merck & Co Company Information Table 73. Merck & Co Business Overview Table 74. Merck & Co Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Merck & Co Veterinary Pain Medication Product Portfolio Table 76. Merck & Co Recent Development Table 77. Medtronic Company Information Table 78. Medtronic Business Overview Table 79. Medtronic Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Medtronic Veterinary Pain Medication Product Portfolio Table 81. Medtronic Recent Development Table 82. Lilly Company Information Table 83. Lilly Business Overview Table 84. Lilly Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Lilly Veterinary Pain Medication Product Portfolio Table 86. Lilly Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Pfizer Veterinary Pain Medication Product Portfolio Table 91. Pfizer Recent Development Table 92. Harbin Bolai Pharmaceutical Co., Ltd. Company Information Table 93. Harbin Bolai Pharmaceutical Co., Ltd. Business Overview Table 94. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 96. Harbin Bolai Pharmaceutical Co., Ltd. Recent Development Table 97. Bostonscientific Company Information Table 98. Bostonscientific Business Overview Table 99. Bostonscientific Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Bostonscientific Veterinary Pain Medication Product Portfolio Table 101. Bostonscientific Recent Development Table 102. Bayer Pharma AG Company Information Table 103. Bayer Pharma AG Business Overview Table 104. Bayer Pharma AG Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Bayer Pharma AG Veterinary Pain Medication Product Portfolio Table 106. Bayer Pharma AG Recent Development Table 107. Baxter Company Information Table 108. Baxter Business Overview Table 109. Baxter Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Baxter Veterinary Pain Medication Product Portfolio Table 111. Baxter Recent Development Table 112. Norbrook Laboratories Company Information Table 113. Norbrook Laboratories Business Overview Table 114. Norbrook Laboratories Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Norbrook Laboratories Veterinary Pain Medication Product Portfolio Table 116. Norbrook Laboratories Recent Development Table 117. Halyard Company Information Table 118. Halyard Business Overview Table 119. Halyard Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Halyard Veterinary Pain Medication Product Portfolio Table 121. Halyard Recent Development Table 122. Forest Laboratories Company Information Table 123. Forest Laboratories Business Overview Table 124. Forest Laboratories Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Forest Laboratories Veterinary Pain Medication Product Portfolio Table 126. Forest Laboratories Recent Development Table 127. Endo International Company Information Table 128. Endo International Business Overview Table 129. Endo International Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Endo International Veterinary Pain Medication Product Portfolio Table 131. Endo International Recent Development Table 132. Elanco Company Information Table 133. Elanco Business Overview Table 134. Elanco Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Elanco Veterinary Pain Medication Product Portfolio Table 136. Elanco Recent Development Table 137. Ceva Sante Animale Company Information Table 138. Ceva Sante Animale Business Overview Table 139. Ceva Sante Animale Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Ceva Sante Animale Veterinary Pain Medication Product Portfolio Table 141. Ceva Sante Animale Recent Development Table 142. Boehringer Ingelheim Company Information Table 143. Boehringer Ingelheim Business Overview Table 144. Boehringer Ingelheim Veterinary Pain Medication Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Boehringer Ingelheim Veterinary Pain Medication Product Portfolio Table 146. Boehringer Ingelheim Recent Development Table 147. North America Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 150. North America Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 151. North America Veterinary Pain Medication Sales Price by Type (2021-2026) & (US$/unit) Table 152. North America Veterinary Pain Medication Sales Price by Type (2027-2032) & (US$/unit) Table 153. North America Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 156. North America Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 157. North America Veterinary Pain Medication Sales Price by Application (2021-2026) & (US$/unit) Table 158. North America Veterinary Pain Medication Sales Price by Application (2027-2032) & (US$/unit) Table 159. North America Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Veterinary Pain Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Veterinary Pain Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. North America Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 164. North America Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 165. North America Veterinary Pain Medication Sales Price by Country (2021-2026) & (US$/unit) Table 166. North America Veterinary Pain Medication Sales Price by Country (2027-2032) & (US$/unit) Table 167. United States Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 168. Canada Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 169. Mexico Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 170. Europe Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 173. Europe Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 174. Europe Veterinary Pain Medication Sales Price by Type (2021-2026) & (US$/unit) Table 175. Europe Veterinary Pain Medication Sales Price by Type (2027-2032) & (US$/unit) Table 176. Europe Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 179. Europe Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 180. Europe Veterinary Pain Medication Sales Price by Application (2021-2026) & (US$/unit) Table 181. Europe Veterinary Pain Medication Sales Price by Application (2027-2032) & (US$/unit) Table 182. Europe Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Veterinary Pain Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Veterinary Pain Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Europe Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 187. Europe Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 188. Europe Veterinary Pain Medication Sales Price by Country (2021-2026) & (US$/unit) Table 189. Europe Veterinary Pain Medication Sales Price by Country (2027-2032) & (US$/unit) Table 190. Germany Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 191. France Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 192. U.K. Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 193. Italy Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 194. Russia Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 195. Spain Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 198. Sweden Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 199. Poland Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 200. China Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 201. China Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 202. China Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 203. China Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 204. China Veterinary Pain Medication Sales Price by Type (2021-2026) & (US$/unit) Table 205. China Veterinary Pain Medication Sales Price by Type (2027-2032) & (US$/unit) Table 206. China Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 207. China Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 208. China Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 209. China Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 210. China Veterinary Pain Medication Sales Price by Application (2021-2026) & (US$/unit) Table 211. China Veterinary Pain Medication Sales Price by Application (2027-2032) & (US$/unit) Table 212. Asia Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 215. Asia Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 216. Asia Veterinary Pain Medication Sales Price by Type (2021-2026) & (US$/unit) Table 217. Asia Veterinary Pain Medication Sales Price by Type (2027-2032) & (US$/unit) Table 218. Asia Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 221. Asia Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 222. Asia Veterinary Pain Medication Sales Price by Application (2021-2026) & (US$/unit) Table 223. Asia Veterinary Pain Medication Sales Price by Application (2027-2032) & (US$/unit) Table 224. Asia Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Veterinary Pain Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Veterinary Pain Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 228. Asia Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 229. Asia Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 230. Asia Veterinary Pain Medication Sales Price by Country (2021-2026) & (US$/unit) Table 231. Asia Veterinary Pain Medication Sales Price by Country (2027-2032) & (US$/unit) Table 232. Japan Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 233. South Korea Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 234. India Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 235. Australia Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Veterinary Pain Medication Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Veterinary Pain Medication Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 241. SAMEA Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 242. SAMEA Veterinary Pain Medication Sales Price by Type (2021-2026) & (US$/unit) Table 243. SAMEA Veterinary Pain Medication Sales Price by Type (2027-2032) & (US$/unit) Table 244. SAMEA Veterinary Pain Medication Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Veterinary Pain Medication Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 247. SAMEA Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 248. SAMEA Veterinary Pain Medication Sales Price by Application (2021-2026) & (US$/unit) Table 249. SAMEA Veterinary Pain Medication Sales Price by Application (2027-2032) & (US$/unit) Table 250. SAMEA Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Veterinary Pain Medication Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Veterinary Pain Medication Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 254. SAMEA Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 255. SAMEA Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 256. SAMEA Veterinary Pain Medication Sales Price by Country (2021-2026) & (US$/unit) Table 257. SAMEA Veterinary Pain Medication Sales Price by Country (2027-2032) & (US$/unit) Table 258. Brazil Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 259. Argentina Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 260. Chile Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 261. Colombia Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 262. Peru Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 264. Israel Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 265. UAE Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 266. Turkey Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 267. Iran Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 268. Egypt Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Veterinary Pain Medication Distributors List Table 272. Veterinary Pain Medication Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Veterinary Pain Medication Image Figure 2. Global Veterinary Pain Medication Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Pain Medication Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Medicines Image Figure 5. Oral Medicines Image Figure 6. Global Veterinary Pain Medication Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Veterinary Pain Medication Market Size Share 2021 VS 2025 VS 2032 Figure 8. Veterinary Hospitals Image Figure 9. Veterinary Clinics Image Figure 10. Others Image Figure 11. Global Veterinary Pain Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Figure 13. Global Veterinary Pain Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Veterinary Pain Medication Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Veterinary Pain Medication Revenue Market Share by Region (2021-2032) Figure 16. Global Veterinary Pain Medication Sales (2021-2032) & (k units) Figure 17. Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Veterinary Pain Medication Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Veterinary Pain Medication Sales YoY (2021-2032) & (k units) Figure 20. Europe Veterinary Pain Medication Sales YoY (2021-2032) & (k units) Figure 21. China Veterinary Pain Medication Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Veterinary Pain Medication Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Veterinary Pain Medication Sales YoY (2021-2032) & (k units) Figure 24. Global Veterinary Pain Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Veterinary Pain Medication Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Veterinary Pain Medication Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Veterinary Pain Medication Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Veterinary Pain Medication Revenue Market Share by Type (2021-2032) Figure 30. Global Veterinary Pain Medication Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Veterinary Pain Medication Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Veterinary Pain Medication Sales Market Share by Type (2021-2032) Figure 33. Global Veterinary Pain Medication Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Veterinary Pain Medication Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Veterinary Pain Medication Revenue Market Share by Application (2021-2032) Figure 36. Global Veterinary Pain Medication Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Veterinary Pain Medication Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Veterinary Pain Medication Sales Market Share by Application (2021-2032) Figure 39. North America Veterinary Pain Medication Revenue Share by Type (2021-2032) Figure 40. North America Veterinary Pain Medication Sales Share by Type (2021-2032) Figure 41. North America Veterinary Pain Medication Revenue Share by Application (2021-2032) Figure 42. North America Veterinary Pain Medication Sales Share by Application (2021-2032) Figure 43. North America Veterinary Pain Medication Revenue Share by Country (2021-2032) Figure 44. North America Veterinary Pain Medication Sales Share by Country (2021-2032) Figure 45. Europe Veterinary Pain Medication Revenue Share by Type (2021-2032) Figure 46. Europe Veterinary Pain Medication Sales Share by Type (2021-2032) Figure 47. Europe Veterinary Pain Medication Revenue Share by Application (2021-2032) Figure 48. Europe Veterinary Pain Medication Sales Share by Application (2021-2032) Figure 49. Europe Veterinary Pain Medication Revenue Share by Country (2021-2032) Figure 50. Europe Veterinary Pain Medication Sales Share by Country (2021-2032) Figure 51. China Veterinary Pain Medication Revenue Share by Type (2021-2032) Figure 52. China Veterinary Pain Medication Sales Share by Type (2021-2032) Figure 53. China Veterinary Pain Medication Revenue Share by Application (2021-2032) Figure 54. China Veterinary Pain Medication Sales Share by Application (2021-2032) Figure 55. Asia Veterinary Pain Medication Revenue Share by Type (2021-2032) Figure 56. Asia Veterinary Pain Medication Sales Share by Type (2021-2032) Figure 57. Asia Veterinary Pain Medication Revenue Share by Application (2021-2032) Figure 58. Asia Veterinary Pain Medication Sales Share by Application (2021-2032) Figure 59. Asia Veterinary Pain Medication Revenue Share by Country (2021-2032) Figure 60. Asia Veterinary Pain Medication Sales Share by Country (2021-2032) Figure 61. SAMEA Veterinary Pain Medication Revenue Share by Type (2021-2032) Figure 62. SAMEA Veterinary Pain Medication Sales Share by Type (2021-2032) Figure 63. SAMEA Veterinary Pain Medication Revenue Share by Application (2021-2032) Figure 64. SAMEA Veterinary Pain Medication Sales Share by Application (2021-2032) Figure 65. SAMEA Veterinary Pain Medication Revenue Share by Country (2021-2032) Figure 66. SAMEA Veterinary Pain Medication Sales Share by Country (2021-2032) Figure 67. Veterinary Pain Medication Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Veterinary Pain Medication Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Medicines
  • Oral Medicines
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Others
Companies covered
  • Zoetis
  • Ringpu Bio-technology
  • Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  • Merck & Co
  • Medtronic
  • Lilly
  • Pfizer
  • Harbin Bolai Pharmaceutical Co., Ltd.
  • Bostonscientific
  • Bayer Pharma AG
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Pain Medication Market by Type
  3. 1.2.1 Global Veterinary Pain Medication Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection Medicines
  5. 1.2.3 Oral Medicines
  6. 1.3 Veterinary Pain Medication Market by Application
  7. 1.3.1 Global Veterinary Pain Medication Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Veterinary Hospitals
  9. 1.3.3 Veterinary Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Veterinary Pain Medication Market Dynamics
  1. 2.1 Veterinary Pain Medication Industry Trends
  2. 2.2 Veterinary Pain Medication Industry Drivers
  3. 2.3 Veterinary Pain Medication Industry Opportunities and Challenges
  4. 2.4 Veterinary Pain Medication Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Pain Medication Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Pain Medication Revenue by Region
  3. 3.2.1 Global Veterinary Pain Medication Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Pain Medication Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Pain Medication Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Pain Medication Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Pain Medication Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Pain Medication Sales by Region
  9. 3.4.1 Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Pain Medication Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Pain Medication Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Pain Medication Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Pain Medication Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Pain Medication Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Pain Medication Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Pain Medication Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Pain Medication Sales by Manufacturers
  6. 4.2.1 Global Veterinary Pain Medication Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Pain Medication Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Pain Medication Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Pain Medication Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Pain Medication Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Pain Medication Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Pain Medication Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Pain Medication Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Pain Medication Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Pain Medication Tier 1, Tier 2, and Tier 3
5 Veterinary Pain Medication Market by Type
  1. 5.1 Global Veterinary Pain Medication Revenue by Type
  2. 5.1.1 Global Veterinary Pain Medication Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Pain Medication Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Pain Medication Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Pain Medication Sales by Type
  6. 5.2.1 Global Veterinary Pain Medication Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Pain Medication Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Veterinary Pain Medication Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Pain Medication Price by Type
6 Veterinary Pain Medication Market by Application
  1. 6.1 Global Veterinary Pain Medication Revenue by Application
  2. 6.1.1 Global Veterinary Pain Medication Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Pain Medication Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Pain Medication Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Pain Medication Sales by Application
  6. 6.2.1 Global Veterinary Pain Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Pain Medication Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Veterinary Pain Medication Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Pain Medication Price by Application
7 Company Profiles
  1. 7.1 Zoetis
  2. 7.1.1 Zoetis Company Information
  3. 7.1.2 Zoetis Business Overview
  4. 7.1.3 Zoetis Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zoetis Veterinary Pain Medication Product Portfolio
  6. 7.1.5 Zoetis Recent Developments
  7. 7.2 Ringpu Bio-technology
  8. 7.2.1 Ringpu Bio-technology Company Information
  9. 7.2.2 Ringpu Bio-technology Business Overview
  10. 7.2.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ringpu Bio-technology Veterinary Pain Medication Product Portfolio
  12. 7.2.5 Ringpu Bio-technology Recent Developments
  13. 7.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  14. 7.3.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  18. 7.3.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Merck & Co
  20. 7.4.1 Merck & Co Company Information
  21. 7.4.2 Merck & Co Business Overview
  22. 7.4.3 Merck & Co Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co Veterinary Pain Medication Product Portfolio
  24. 7.4.5 Merck & Co Recent Developments
  25. 7.5 Medtronic
  26. 7.5.1 Medtronic Company Information
  27. 7.5.2 Medtronic Business Overview
  28. 7.5.3 Medtronic Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Medtronic Veterinary Pain Medication Product Portfolio
  30. 7.5.5 Medtronic Recent Developments
  31. 7.6 Lilly
  32. 7.6.1 Lilly Company Information
  33. 7.6.2 Lilly Business Overview
  34. 7.6.3 Lilly Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lilly Veterinary Pain Medication Product Portfolio
  36. 7.6.5 Lilly Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Veterinary Pain Medication Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Harbin Bolai Pharmaceutical Co., Ltd.
  44. 7.8.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Harbin Bolai Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  48. 7.8.5 Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Bostonscientific
  50. 7.9.1 Bostonscientific Company Information
  51. 7.9.2 Bostonscientific Business Overview
  52. 7.9.3 Bostonscientific Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bostonscientific Veterinary Pain Medication Product Portfolio
  54. 7.9.5 Bostonscientific Recent Developments
  55. 7.10 Bayer Pharma AG
  56. 7.10.1 Bayer Pharma AG Company Information
  57. 7.10.2 Bayer Pharma AG Business Overview
  58. 7.10.3 Bayer Pharma AG Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Bayer Pharma AG Veterinary Pain Medication Product Portfolio
  60. 7.10.5 Bayer Pharma AG Recent Developments
  61. 7.11 Baxter
  62. 7.11.1 Baxter Company Information
  63. 7.11.2 Baxter Business Overview
  64. 7.11.3 Baxter Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Baxter Veterinary Pain Medication Product Portfolio
  66. 7.11.5 Baxter Recent Developments
  67. 7.12 Norbrook Laboratories
  68. 7.12.1 Norbrook Laboratories Company Information
  69. 7.12.2 Norbrook Laboratories Business Overview
  70. 7.12.3 Norbrook Laboratories Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Norbrook Laboratories Veterinary Pain Medication Product Portfolio
  72. 7.12.5 Norbrook Laboratories Recent Developments
  73. 7.13 Halyard
  74. 7.13.1 Halyard Company Information
  75. 7.13.2 Halyard Business Overview
  76. 7.13.3 Halyard Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Halyard Veterinary Pain Medication Product Portfolio
  78. 7.13.5 Halyard Recent Developments
  79. 7.14 Forest Laboratories
  80. 7.14.1 Forest Laboratories Company Information
  81. 7.14.2 Forest Laboratories Business Overview
  82. 7.14.3 Forest Laboratories Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Forest Laboratories Veterinary Pain Medication Product Portfolio
  84. 7.14.5 Forest Laboratories Recent Developments
  85. 7.15 Endo International
  86. 7.15.1 Endo International Company Information
  87. 7.15.2 Endo International Business Overview
  88. 7.15.3 Endo International Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Endo International Veterinary Pain Medication Product Portfolio
  90. 7.15.5 Endo International Recent Developments
  91. 7.16 Elanco
  92. 7.16.1 Elanco Company Information
  93. 7.16.2 Elanco Business Overview
  94. 7.16.3 Elanco Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Elanco Veterinary Pain Medication Product Portfolio
  96. 7.16.5 Elanco Recent Developments
  97. 7.17 Ceva Sante Animale
  98. 7.17.1 Ceva Sante Animale Company Information
  99. 7.17.2 Ceva Sante Animale Business Overview
  100. 7.17.3 Ceva Sante Animale Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Ceva Sante Animale Veterinary Pain Medication Product Portfolio
  102. 7.17.5 Ceva Sante Animale Recent Developments
  103. 7.18 Boehringer Ingelheim
  104. 7.18.1 Boehringer Ingelheim Company Information
  105. 7.18.2 Boehringer Ingelheim Business Overview
  106. 7.18.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Boehringer Ingelheim Veterinary Pain Medication Product Portfolio
  108. 7.18.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Veterinary Pain Medication Market Size by Type
  2. 8.1.1 North America Veterinary Pain Medication Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Pain Medication Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Pain Medication Price by Type (2021-2032)
  5. 8.2 North America Veterinary Pain Medication Market Size by Application
  6. 8.2.1 North America Veterinary Pain Medication Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Pain Medication Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Pain Medication Price by Application (2021-2032)
  9. 8.3 North America Veterinary Pain Medication Market Size by Country
  10. 8.3.1 North America Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Pain Medication Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Pain Medication Market Size by Type
  2. 9.1.1 Europe Veterinary Pain Medication Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Pain Medication Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Pain Medication Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Pain Medication Market Size by Application
  6. 9.2.1 Europe Veterinary Pain Medication Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Pain Medication Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Pain Medication Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Pain Medication Market Size by Country
  10. 9.3.1 Europe Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Pain Medication Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Veterinary Pain Medication Market Size by Type
  2. 10.1.1 China Veterinary Pain Medication Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Pain Medication Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Pain Medication Price by Type (2021-2032)
  5. 10.2 China Veterinary Pain Medication Market Size by Application
  6. 10.2.1 China Veterinary Pain Medication Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Pain Medication Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Pain Medication Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Pain Medication Market Size by Type
  2. 11.1.1 Asia Veterinary Pain Medication Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Pain Medication Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Pain Medication Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Pain Medication Market Size by Application
  6. 11.2.1 Asia Veterinary Pain Medication Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Pain Medication Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Pain Medication Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Pain Medication Market Size by Country
  10. 11.3.1 Asia Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Pain Medication Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Pain Medication Market Size by Type
  2. 12.1.1 SAMEA Veterinary Pain Medication Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Pain Medication Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Pain Medication Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Pain Medication Market Size by Application
  6. 12.2.1 SAMEA Veterinary Pain Medication Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Pain Medication Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Pain Medication Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Pain Medication Market Size by Country
  10. 12.3.1 SAMEA Veterinary Pain Medication Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Pain Medication Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Pain Medication Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Pain Medication Value Chain Analysis
  2. 13.1.1 Veterinary Pain Medication Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Pain Medication Production Mode & Process
  6. 13.2 Veterinary Pain Medication Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Pain Medication Distributors
  9. 13.2.3 Veterinary Pain Medication Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research